Want to hire this expert for a project? Request a quote for free.
Profile Details
Create Project
USD 50 /hr
Hire Dr. Farha M.
India
USD 50 /hr
PhD Diagnostics Consultant | ELISA & LFA Development | Antibody Validation & Development with 10 years of experience
Profile Summary
Subject Matter Expertise
Services
Writing
Technical Writing
Research
Scientific and Technical Research
Consulting
Scientific and Technical Consulting
Product Development
Stability/Shelf Life Testing,
Product Evaluation,
Product Validation,
Concept Development,
Prototyping
Work Experience
Principle Scientist
Advinogen Innovations
November 2025 - Present
Principle Scientist
Advinogen Innovations
October 2025 - Present ![]()
Project Research Scientist-II
Translational Health Science and Technology Institute
March 2024 - October 2025 ![]()
Project Research Scientist-II
THSTI
March 2024 - October 2025
Senior project associate
Translational Health Science and Technology Institute
April 2022 - March 2023 ![]()
Education
Doctor of Philosophy (Ph.D)
Translational Health Science and Technology Institute
July 2016 - March 2022
M.Sc (Master of Science)
Banasthali University
July 2012 - July 2014
Certifications
- Certification details not provided.
Publications
JOURNAL ARTICLE
Farha Mehdi, Oinam Ningthemmani Singh, Umang Berry, Garima Joshi, Tejeswara Rao Asuru, Kannan Chandrasekar, Sriram Narayanan, Puneet Srivastava, Mahima Tiwari, Souvick Chattopadhyay, et al. (2025). Comparison of immunogenicity and protection efficacy of self-amplifying and circular mRNA vaccines against SARS-CoV-2 . iScience.
Farha Mehdi, Guruprasad R Medigeshi, Gaurav Batra, Deepika Rathna Murugesan, Ramachandran Thiruvengadam, Souvick Chattopadhyay, Bhabatosh Das, Mudita Gosain, Ayushi, Janmejay Singh, et al. (2022). Sub-optimal neutralisation of omicron (B.1.1.529) variant by antibodies induced by vaccine alone or SARS-CoV-2 Infection plus vaccine (hybrid immunity) post 6-months . eBioMedicine.
S. Yadav, F. Mehdi, S.K. Sinha, N. Kaushik, G. Batra (2022). Development of dengue virus complex-specific IgG immunoassay, with high sensitivity, using envelope domain III variants . International Journal of Infectious Diseases.
F. Mehdi, S. Roy Chowdhury, S. Yadav, J. Kansana, G. Batra (2022). Development of highly sensitive DENV NS1 antigen detection Immunoassay . International Journal of Infectious Diseases.
Farha Mehdi, Ramachandran Thiruvengadam, Souvick Chattopadhyay, Bapu Koundinya Desiraju, Susmita Chaudhuri, Savita Singh, Vandita Bhartia, Pallavi Kshetrapal, Uma Chandra Mouli Natchu, Nitya Wadhwa, et al. (2021). Longitudinal Serology of SARS-CoV-2-Infected Individuals in India: A Prospective Cohort Study . The American Journal of Tropical Medicine and Hygiene.
Farha Mehdi, Souvick Chattopadhyay, Ramachandran Thiruvengadam, Sarla Yadav, Manjit Kumar, Sangita Kumari Sinha, Sandeep Goswami, Pallavi Kshetrapal, Nitya Wadhwa, Uma Chandramouli Natchu, et al. (2021). Development of a Fast SARS-CoV-2 IgG ELISA, Based on Receptor-Binding Domain, and Its Comparative Evaluation Using Temporally Segregated Samples From RT-PCR Positive Individuals . Frontiers in Microbiology.
Farha Mehdi, Teppo Salminen, Deepak Rohila, Manjit Kumar, Sheikh M. Talha, John Antony Jude Prakash, Navin Khanna, Kim Pettersson, Gaurav Batra (2020). Ultrasensitive and Robust Point-of-Care Immunoassay for the Detection of <i>Plasmodium falciparum</i> Malaria . Analytical Chemistry.
Farha Mehdi, Susmita Chaudhuri, Ramachandran Thiruvengadam, Souvick Chattopadhyay, Pallavi Kshetrapal, Tripti Shrivastava, Bapu Koundinya Desiraju, Gaurav Batra, Gagandeep Kang, Shinjini Bhatnagar (2020). Comparative evaluation of SARS-CoV-2 IgG assays in India . Journal of Clinical Virology.
PREPRINT
Farha Mehdi, Animesh Ray, Komal Singh, Souvick Chattopadhyay, Gaurav Batra, Aakansha Gupta, Ayush Agarwal, M Bhavesh, Shubham Sahni, R Chaithra, et al. (2020). Seroprevalence of anti-SARS-CoV-2 IgG antibodies in hospitalized patients at a tertiary referral center in North India .